CCI
TGTX icon

Columbus Circle Investors’s TG Therapeutics TGTX Stock Holding History

Columbus Circle Investors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-165,510
Closed -$679K – 177
2018
Q4 		$679K Sell
165,510
-75,891
-31% -$377K 0.02% 145
2018
Q3 		$1.35M Sell
241,401
-505,884
-68% -$5.78M 0.03% 171
2018
Q2 		$9.83M Sell
747,285
-13,745
-2% -$189K 0.2% 139
2018
Q1 		$10.8M Buy
761,030
+215,976
+40% +$2.76M 0.22% 131
2017
Q4 		$4.47M Sell
545,054
-987,857
-64% -$8.63M 0.08% 153
2017
Q3 		$18.2M Buy
1,532,911
+136,515
+10% +$1.55M 0.31% 100
2017
Q2 		$14M Buy
1,396,396
+391,975
+39% +$4.39M 0.23% 105
2017
Q1 		$11.7M Buy
1,004,421
+227,722
+29% +$1.63M 0.16% 138
2016
Q4 		$3.61M Buy
776,699
+141,339
+22% +$829K 0.05% 204
2016
Q3 		$4.92M Buy
635,360
+57,591
+10% +$370K 0.05% 209
2016
Q2 		$3.5M Sell
577,769
-34,945
-6% -$284K 0.04% 204
2016
Q1 		$5.22M Sell
612,714
-92,675
-13% -$811K 0.05% 213
2015
Q4 		$8.41M Buy
705,389
+44,190
+7% +$558K 0.07% 205
2015
Q3 		$6.67M Buy
661,199
+196,019
+42% +$2.92M 0.05% 214
2015
Q2 		$7.72M Buy
465,180
+3,781
+0.8% +$59.9K 0.05% 223
2015
Q1 		$7.14M Buy
461,399
+231,668
+101% +$3.51M 0.05% 223
2014
Q4 		$3.64M Sell
229,731
-227,981
-50% -$2.97M 0.03% 236
2014
Q3 		$4.88M Buy
457,712
+48,750
+12% +$452K 0.04% 212
2014
Q2 		$3.84M Buy
408,962
+159,717
+64% +$1.02M 0.03% 236
2014
Q1 		$1.72M Buy
249,245
+87,326
+54% +$517K 0.01% 259
2013
Q4 		$631K Buy
+161,919
New +$654K ﹤0.01% 277

Other funds holding TGTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Columbus Circle Investors's TGTX Position: Q1 2019 in Review

Columbus Circle Investors sold out of TG Therapeutics (TGTX) in Q1 2019, closing a stake of 165,510 shares — an estimated $679K sold.

Columbus Circle Investors first reported a position in TGTX in Q4 2013 and held it in 21 quarters. The position peaked at $18.2M in Q3 2017. 113 funds tracked by Wall St. Rank hold TGTX as of Q1 2019.

  • Columbus Circle Investors reported no remaining TG Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Columbus Circle Investors sold 165,510 TG Therapeutics shares in Q1 2019, an estimated $679K.
  • Columbus Circle Investors first reported a position in TG Therapeutics in Q4 2013 and held it in 21 quarters.
  • Columbus Circle Investors's TG Therapeutics position peaked at $18.2M in Q3 2017.
  • 113 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2019.

Based on Columbus Circle Investors's 13F filing for Q1 2019, filed 22 Apr 2019.